Relationships between 6-month post-treatment health outcomes and 12-month post-treatment PTSD scores
| Unadjusted β (95% CI) | Adjusted β (95% CI) | |||
|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | ||
| Depression (PHQ-9) | 0.80 (0.62 to 0.98)* | 0.79 (0.60 to 0.98)* | 0.35 (0.07 to 0.63)* | 0.15 (−0.12 to 0.41) |
| Generalised anxiety (GAD-7) | 0.95 (0.73 to 1.18)* | 0.93 (0.70 to 1.16)* | 0.26 (−0.10 to 6.63) | 0.05 (−0.40 to 0.29) |
| Anger (DAR-5) | 0.52 (0.30 to 0.75)* | 0.55 (0.32 to 0.78)* | 0.08 (−0.33 to 0.17) | 0.03 (−0.38 to 0.07) |
| Alcohol (AUDIT) | 0.24 (0.07 to 0.42)* | 0.26 (0.07 to 0.44)* | 0.19 (0.04 to 0.35)* | 0.18 (0.03 to 0.32)* |
| Functioning (WSAS) | 0.60 (0.47 to 0.73)* | 0.61 (0.47 to 0.74)* | 0.37 (0.20 to 0.54)* | 0.24 (0.08 to 0.41)* |
Model 1 is β adjusted for age and employment status. Model 2 is additionally adjusted for 6-month health outcomes listed above. Model 3, in addition to Model 2, is adjusted for 6-month post-treatment PSS-I score.
*p≤0.05.
AUDIT, Alcohol Use Disorders Identification Test; DAR-5, five-item Dimensions of Anger Reactions; GAD-7, Generalised Anxiety Disorders measure; PSS-I, PTSD Symptom Scale Interview; PTSD, post-traumatic stress disorder; WSAS, Work and Social Adjustment Scale.